Crossmark

Detection of Blastocystis species in immunocompromised patients (cancer, diabetes mellitus, and chronic renal diseases) by restriction fragment length polymorphism (RFLP)

Crossref DOI link: https://doi.org/10.1186/s43088-025-00631-z

Published Online: 2025-04-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdellatif, Manal Z. M.

Abdel-Hafeez, Ekhlas H.

Belal, Usama S.

Abdelgelil, Noha H.

Marey, Heba

Nasr, Manar M. S. A.

Abdel-Fatah, Mohamed Mahmoud
License Information

Text and Data Mining valid from 2025-04-30

Version of Record valid from 2025-04-30
More Information

Article History

Received: 6 January 2025

Accepted: 1 April 2025

First Online: 30 April 2025

Declarations

:

: The study protocol was approved by the Scientific Ethical Committee of the Department of Medical Parasitology in January 2021 (approval No. 2:2021). Written informed consent was obtained from all participants after a complete explanation of the study’s purpose and procedures.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below